Navigation Links
Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
Date:4/22/2009

, utilities, and labor costs, in comparison to the cost of the same type of operations in Beijing.

"According to Chinese government's recent universal healthcare plan, the government will spend RMB850 billion ($124.3 billion) in the next three years to provide accessible and affordable healthcare to the country's 1.3 billion people. We see this as a wonderful opportunity because demands for drugs and active pharmaceutical ingredients ('APIs') are expected to increase and we believe could continue to increase until 2020. We also anticipate the decrease of drugs' pricings due to the open bidding system and government's restrictions on hikes of drugs prices.

"We entered into 2008 with a strong push to increase collections of our outstanding account receivables ('AR') and reduced outstanding AR amount significantly in 2008. We intend to maintain the AR level of 2008 and to request customers to prepay orders prior to our shipment of drugs. We ended the year with committed footprint in Inner Mongolia, the acquisition of intellectual rights of two drugs, application and the submission of two drugs to the SFDA. We achieved our goals for the year and exceeded our financial objectives."

Commentary

The 2008 revenue increase was attributed to wholesale revenues which increased by 57%. The increases were primarily due to strong sales in Brimonidine Tartrate Eye Drops and third party manufactured drugs. 100% of the prescription drugs Lotus sold are covered under the National Health Insurance program. The Company has promoted strongly the sale of Brimonidine Tartrate Eye Drops and gained national exclusive rights to five third-party manufactured prescription drugs. Lotus believes that due to the strong market demand for these drugs, together with the Company's sales and marketing efforts, steady growth is expected in 2009 regardless of the softening of the economy. The decrease in retail sales from L
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
2. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
3. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
4. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
5. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
6. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
7. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
8. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
9. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
10. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
11. Lotus Pharmaceuticals Raises $5 Million in Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products ... Administrative assistant to Executive Assistant to CEO Mitch Gould for Nutritional Products International. ... on your goals. Kathleen graduated from Florida State University with a Bachelor ...
(Date:8/29/2015)... ... 30, 2015 , ... Electronic Informed Consent for Clinical Trials:, ... EDT, http://www.fdanews.com/electronicinformedconsent , The simple fact about electronic informed consent is ... Clinical trial sites can now use audio, video and interactivity to educate participants ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made ... the lives of patients, according to a newly published report. Surviving Mesothelioma has ... full article. , The authors of the new paper focus on several ...
(Date:8/29/2015)... ... ... ProDrop Particles includes over 40 particle backdrops designed for use in ... users can shrink and stretch in the Final Cut Pro X timeline. Choose from ... scale, speed, range, and flare attributes with intuitive controls found in the top-right inspector ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... to freely market and sell Arterosil and Arterosil HP, and that all claims ... (DHS) sued Vascular Health Sciences, LLC (VHS) in the United States District Court ...
Breaking Medicine News(10 mins):Health News:NPI Appoints New Executive Assistant To CEO 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2
... 2009 in TEDA Tianjin, ChinaTEDA Tianjin, China, May 20 ... of API,s and intermediates, and Drug Products to the ... its high potency Active Pharmaceutical Ingredient (API) and Drug ... facility is sited at Asymchem,s TEDA Tianjin 1 location, ...
... Annual award honors the accomplishments of medical education professionals in Texas. ... ... -- TIAA-CREF, a national financial services group and the leading provider ... announced today that it is soliciting statewide nominations for the 2009 ...
... today that three influential independent proxy voting advisory services, RiskMetrics ... recommended that stockholders of Amylin Pharmaceuticals, Inc. (Nasdaq: ... of Directors of Amylin,s at the 2009 Annual Meeting of ... RiskMetrics Group has recommended that Amylin stockholders ...
... N.Y., May 20 VirtualScopics, Inc. (Nasdaq: ... clinical trials, today announced that it has received notification ... compliance with the minimum $1.00 per share bid price ... other applicable standards for continued listing. To regain compliance ...
... , The ghrelin hormone not only stimulates the ... favours the accumulation of lipids in visceral fatty tissue, located ... harmful. This is the conclusion of research undertaken at Metabolic ... in the International Journal of Obesity . , Ghrelin ...
... over 150 scientific studies: Balanced organic diet before and ... The Organic Center (TOC), a leading research institute ... announced today that a balanced, organic diet -- both ... child,s likelihood of being overweight, obese or developing diabetes. ...
Cached Medicine News:Health News:Asymchem Announces Opening of High Potency API and Drug Product Facility 2Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 2Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 3Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 4Health News:Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight 2Health News:Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight 3Health News:VirtualScopics Regains NASDAQ Compliance 2Health News:Action of ghrelin hormone increases appetite and favors accumulation of abdominal fat 2Health News:Action of ghrelin hormone increases appetite and favors accumulation of abdominal fat 3Health News:Studies Reveal Exposure to Pesticides During Pregnancy Increases Risk of Premature Birth, Low-Birth Weight, Neurological Problems and Diabetes 2Health News:Studies Reveal Exposure to Pesticides During Pregnancy Increases Risk of Premature Birth, Low-Birth Weight, Neurological Problems and Diabetes 3
(Date:8/28/2015)... Aug. 28, 2015  Today, in final recognition of ... Lens Health Week, 1-800 Contacts is sharing how to ... contact lens wearers who do not properly care for ... eye infections. Most contact lens wearers ... a clean lens case is sometimes overlooked.  When proper ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rktnl9/investigation ... "Investigation Report on China,s Insulin Aspart Market, 2010-2019" ... by Novo Nordisk, insulin aspart (under the trade ... the treatment of diabetes. Compared with human insulin, ... starts working fast and reports higher peak of ...
(Date:8/28/2015)... , August 28, 2015 The scientific ... collaboration with one of the leading academics in the field ... world record holder in life extension for model animals - ... biology of aging and age-related diseases, primarily, around the stability ... has just been published as "Stability analysis of a model ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3
Full Handle Laseredge Stab Blade Knife, 22.5 blade. Blade tip dimension: 10.7 mm x 1.8 mm x 4.2 mm....
18 gauge straight. Fine tip. Lightweight design offers precise hemostasis. Pencil design minimizes tissue trauma and induced astigmatism. Knurled handle provides a sure grip and better manipulation....
Sharp tip with cutting edge bent to 45 degrees. Fits 19 gauge or 20 gauge instrument port. 21 gauge x 25 mm. 10 per box....
80 inch PVC tubing with connectors and 19 gauge straight, beveled cannula. Fits Bausch & Lomb Surgical cassettes. Allows the safe removal of silicone oil in 10 minutes or less. 3/Box...
Medicine Products: